The Schedule of Pharmaceutical Benefits has been updated. New, Amended and Deleted items can be found on the Summary of Changes page.
The following updates have also been made to the PBS Website on the dates specified.
- PBS subsidy arrangements for diltiazem hydrochloride capsules SSSI - 1 October 2026
- Current Price Disclosure cycle – 2026 October - 1 October 2026
- Active Ingredient Prescribing - 1 October 2026
- Recommendations made by the PBAC – May 2026 Intracycle Meeting - 1 October 2026
- Designated Brands - 1 October 2026
- Section 19A medicines subsidised by the Pharmaceutical Benefits Scheme - 1 October 2026
- Ex-manufacturer price - 1 October 2026
- Formulary Allocations - 1 October 2026
- First New Brand Price Reductions - 1 October 2026
- Items Exempt from Statutory Price Reductions - 1 October 2026
- Drugs subject to Price Disclosure - 1 October 2026
- PBS Frequently Asked Questions - 1 October 2026
- Medicine Status Website - 1 October 2026
- Expression of Interest are now open: Multistakeholder Health Technology Assessment Reform and Implementation Reference Group - 22 September 2026
- PBAC Public Summary Documents – May 2026 meeting - 15 September 2026
- Cost Recovery Fees and Charges - 14 September 2026
- PBAC Update August 2026 - 9 September 2026
- Update to Agenda for the November 2026 PBAC Meeting - 4 September 2026
- Current Price Disclosure cycle – 2026 October - 3 September 2026